Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
97.77
-0.23 (-0.23%)
Apr 10, 2026, 3:00 PM CST
2.50% (1Y)
| Market Cap | 25.88B +8.2% |
| Revenue (ttm) | 810.48M +52.1% |
| Net Income | -162.95M |
| EPS | -0.62 |
| Shares Out | 264.71M |
| PE Ratio | n/a |
| Forward PE | 111.31 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,629,185 |
| Average Volume | 3,668,655 |
| Open | 98.61 |
| Previous Close | 98.00 |
| Day's Range | 96.51 - 101.80 |
| 52-Week Range | 75.10 - 134.17 |
| Beta | -0.00 |
| RSI | 57.22 |
| Earnings Date | Mar 28, 2026 |